The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.
Related Posts
Basic Materials Roundup: Market Talk
Find insight on gold miners, Salzgitter, Incitec Pivot and more in the latest Market Talks covering Basic Materials.
Australia to Tighten Supermarket Regulations, Introduce New Penalties
Australia plans to tighten regulations on supermarkets, including strengthening a code of conduct and introducing new penalties, amid concerns that big grocery chains have too […]
Gucci Owner Kering’s Earnings Hit by Turnaround, China Woes
The French luxury-goods group said it booked revenue of €9.02 billion, down 11% both as reported and on a comparable basis compared with the year-earlier […]